Gain-of-function complement C2 mutant as a supporter of anti-CD20 therapy in murine lymphoma model
2018/29/N/NZ6/01413
Keywords
Descriptors
- NZ6_1: Odporność swoista i nieswoista
- NZ6_2: Immunologia kliniczna
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
Voivodeship: pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 15 – announced on 2018-03-15
- Amount awarded
- 210 000 PLN
- Project start date
- 2019-03-06
- Project end date
- 2022-03-05
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
- Authors:
- Aleksandra Urban, Alan Majeranowski, Grzegorz Stasiłojć , Patrycja Koszałka, Anna Felberg, Michał Taszner, Jan M Zaucha, Marcin Okrój
- Academic press:
- Cancers (Basel) (year: 2022, volume: 14, pages: 5), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cancers14051270 – link to the publication